US DOT MUDDIES THE WATER ON CBD POLICY

Author: Rod Kight

 

The United States Department of Transportation Office of Alcohol Policy and Compliance (DOT) released a “CBD Notice” yesterday (Notice). Although it purports to clarify the law with respect to a certain category of “safety-sensitive” employees, it really just muddies the water. Fortunately, and as the DOT clearly states, the Notice does not have the effect of law.

A copy of the Notice is below. It spends two pages stating the obvious: marijuana is illegal and “it remains unacceptable for any safety-sensitive employee subject to the DOT’s drug testing regulations to use marijuana.” It goes on to state that CBD use is not a legitimate medical explanation for a positive test result for marijuana. Moreover, a drug test confirmed at the “appropriate cutoffs” (meaning levels of tetrahydrocannabinol (THC) metabolites above which are considered prima facie evidence of illegal drug use) will be deemed to be confirmation of illegal drug use.

This Notice is directed to the following categories of employees, as defined under 49 CFR part 40 (Part 40): pilots, school bus drivers, truck drivers, train engineers, transit vehicle operators, aircraft maintenance personnel, fire-armed transit security personnel, ship captains, and pipeline emergency response and personnel.

The Notice appears to address the very real issue of testing positive for marijuana from use of lawful, hemp-derived products. (Click here to read about cannabis employment testing.) Under DOT Rules, the confirmation cutoff for marijuana metabolites, including THC, is 15 nanograms per milliliter. While it is unlikely that a person who consumes a typical amount of hemp extract/ CBD would test positive for marijuana under this cutoff, it is far from impossible. In fact, supposedly “THC Free” CBD products can contain sufficient quantities of THC to register in urine. Virtually no marijuana product, including CBD isolate, is totally free of all THC.

There is a legitimate discussion to be had about the use of hemp/CBD products in the contest of employees subject to drug testing. There is also a legitimate discussion to be had about whether it is possible to correlate impairment for operating vehicles and machinery with levels of THC metabolites in the blood. Unfortunately, the DOT missed each of these opportunities with the Notice. Instead, it managed to reiterate the well-known fact that safety-sensitive employees are prohibited from using marijuana while simultaneously creating confusion about CBD.

Here is the Notice:

February 19, 2020

Rod Kight is an international cannabis and hemp attorney. He speaks at cannabis conferences across the country, drafts and presents cannabis legislation to foreign governments, is regularly quoted on cannabis matters in the media, and maintains the Kight on Cannabis legal blog, where he discusses legal issues affecting the cannabis industry. You can contact him here.

Top 200 Cannabis Lawyers

Cannabis Law Journal – Editorial Board Members

Editor – Sean Hocking

Author Bios

Canada
Matt Maurer – Minden Gross
Jeff Hergot – Wildboer Dellelce LLP

Costa Rica
Tim Morales – The Cannabis Industry Association Costa Rica

Nicaragua
Elvin Rodríguez Fabilena

USA

General
Julie Godard
Carl L Rowley -Thompson Coburn LLP

Arizona
Jerry Chesler – Chesler Consulting

California
Ian Stewart – Wilson Elser Moskowitz Edelman & Dicker LLP
Otis Felder – Wilson Elser Moskowitz Edelman & Dicker LLP
Lance Rogers – Greenspoon Marder – San Diego
Jessica McElfresh -McElfresh Law – San Diego
Tracy Gallegos – Partner – Fox Rothschild

Colorado
Adam Detsky – Knight Nicastro
Dave Rodman – Dave Rodman Law Group
Peter Fendel – CMR Real Estate Network
Nate Reed – CMR Real Estate Network

Florida
Matthew Ginder – Greenspoon Marder
David C. Kotler – Cohen Kotler

Illinois
William Bogot – Fox Rothschild

Massachusetts
Valerio Romano, Attorney – VGR Law Firm, PC

Nevada
Neal Gidvani – Snr Assoc: Greenspoon Marder
Phillip Silvestri – Snr Assoc: Greenspoon Marder

Tracy Gallegos – Associate Fox Rothschild

New Jersey

Matthew G. Miller – MG Miller Intellectual Property Law LLC
Daniel T. McKillop – Scarinci Hollenbeck, LLC

New York
Gregory J. Ryan, Esq. Tesser, Ryan & Rochman, LLP
Tim Nolen Tesser, Ryan & Rochman, LLP
Cadwalader, Wickersham & Taft LLP

Oregon
Paul Loney & Kristie Cromwell – Loney Law Group
William Stewart – Half Baked Labs

Pennsylvania
Andrew B. Sacks – Managing Partner Sacks Weston Diamond
William Roark – Principal Hamburg, Rubin, Mullin, Maxwell & Lupin
Joshua Horn – Partner Fox Rothschild

Washington DC
Teddy Eynon – Partner Fox Rothschild